Company Directory > Pharma > Fidelity Investments
Fidelity Investments (FMR LLC) is one of the world's largest financial services providers and asset managers, with over $5.9 trillion in discretionary assets under management and $15.1 trillion in assets under administration as of late 2024. While primarily a financial services firm, Fidelity is a critical pillar of the pharmaceutical and biotechnology ecosystem, serving as a major institutional investor in nearly every global 'Big Pharma' company and a prolific backer of emerging biotechs. The firm exerts influence in the life sciences sector through its dedicated venture capital arms, F-Prime Capital (formerly Fidelity Biosciences) and Eight Roads, which have backed hundreds of healthcare companies including Moderna and Denali Therapeutics. Additionally, Fidelity manages specialized sector funds such as the Fidelity Select Biotechnology Portfolio (FBIOX) and the Fidelity Select Pharmaceuticals Portfolio (PHREX), making it a primary source of capital for clinical-stage drug development and commercial-scale pharmaceutical operations.
CLASSIFICATION
Company Type:Pharma
Industry:Financial Services
Sub-Industry:Asset Management / Venture Capital
SIZE & FINANCIALS
Employees:10000+
Revenue:$32.7B
Founded:1946
Ownership:private
Status:operating
FUNDING
Stage:Late Stage
PIPELINE
Stage:Commercial
Lead Drug Stage:N/A (Investment Firm)
Modalities:Small molecule, mAb, Cell therapy, Gene therapy, RNA, Radiopharmaceuticals
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:F-Prime Capital, Eight Roads, Fidelity International (FIL), Strategic Advisers LLC, Fidelity Digital Assets
Key Partnerships:Eli Lilly (Co-investor in Aktis Oncology), RA Capital Management (Co-investor in Parabilis Medicines), Janus Henderson (Co-investor in biotech funding rounds)
COMPETITION
Position:Leader
Competitors:Vanguard Group, BlackRock, Charles Schwab, OrbiMed Advisors (Biotech VC), ARCH Venture Partners (Biotech VC)
LEADERSHIP
Key Executives:
Abigail Johnson - Chairman and CEO
Kevin Barry - Chief Financial Officer
Rajiv Kaul - Portfolio Manager, Select Biotechnology
Board Members:Abigail Johnson, Edward Johnson IV
LINKS
Website:fmr.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Fidelity Investments. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.